Cargando…
5613082 CD34+ HEMATOPOIETIC STEM CELL COUNT AS NOVEL BIOMARKER FOR PREDICTING VASCULAR EVENTS IN EGYPTIAN CHILDREN WITH SICKLE CELL DISEASE
Autores principales: | Ellaboudy, M.A.E., Hussien, N.H.A., Ismail, M.A.I., Okba, A.A.M., Ibrahim, R.A.I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112599/ http://dx.doi.org/10.1097/01.HS9.0000928336.93610.00 |
Ejemplares similares
-
5596737 RETINOPATHY IN EGYPTIAN PATIENTS WITH SICKLE CELL DISEASE
por: Hassan, T.H., et al.
Publicado: (2023) -
Safety and efficacy of plerixafor dose escalation for the mobilization of CD34(+) hematopoietic progenitor cells in patients with sickle cell disease: interim results
por: Boulad, Farid, et al.
Publicado: (2018) -
P-028: CIRCULATING CD34+CD235A+ CELL COUNT CORRELATES WITH LEVELS OF HBF IN SICKLE CELL ANEMIA PATIENTS UNDER HYDROXYUREA TREATMENT
por: J., MILHOMENS, et al.
Publicado: (2022) -
Hematopoietic Cell Transplantation for Sickle Cell Disease
por: Krishnamurti, Lakshmanan
Publicado: (2021) -
The hematopoietic saga of clonality in sickle cell disease
por: Stonestrom, Aaron J., et al.
Publicado: (2022)